11 research outputs found

    Impact of lung volume (VL) and blood volume (Qb) on .

    No full text
    <p>(A) Effect of three levels of VL, (i) 30, (ii) 20 and (iii) 10 ml kg<sup>−1</sup>, on arterial () and mixed venous () O<sub>2</sub> desaturation during apnea. (B) Sensitivity of to changes in V<sub>L</sub>. Note that reduced V<sub>L</sub> has a strong impact on and but no impact on . (C) Effect of three levels of Qb, (iv) 120, (v) 80 and (iv) 40 ml kg<sup>−1</sup>, on and during apnea. (D) Sensitivity of to changes in Qb. Note that reduced Qb has little impact on or but has a large impact on . n = ‘normal’ values; S1, stage 1 slope; S2, stage 2 slope.</p

    Impact of cardiac output () on .

    No full text
    <p>(A) Effect of three levels of resting , (i) 375 ml min<sup>−1</sup>kg<sup>−1</sup>, (ii) 250 ml min<sup>−1</sup>kg<sup>−1</sup>, and (iii) 125 ml min<sup>−1</sup>kg<sup>−1</sup>, on arterial () and mixed venous () O<sub>2</sub> during apnea. Note that reduced elevates , associated with a reduction in resting and reduction in at the stage 1–2 transition or inflection point (shown by short black lines). (B) Sensitivity of to changes in . Note the strong influence of on , but negligible effect on and . (C) Simulations in (A) repeated for a step change in at apnea onset by (iv) +125 ml min<sup>−1</sup>kg<sup>−1</sup> (e.g. tachycardia), (v) 0 ml min<sup>−1</sup>kg<sup>−1</sup>, and (vi) −125 ml min<sup>−1</sup>kg<sup>−1</sup> (e.g. bradycardia), following resting . Note that the transient effect of is opposite to the resting effect of on arterial desaturation during apnea. (D) Sensitivity of to acute changes in during apnea. Note the strong influence of a step-change in on , but negligible effect on and . n = ‘normal’ values.</p

    Impact of pre-apneic alveolar (ventilation, supplemental O<sub>2</sub>) on .

    No full text
    <p>(A) Effect of three levels of alveolar (), (i) 100 mmHg, (ii) 80 mmHg and (iii) 60 mmHg, on arterial () and mixed venous () O<sub>2</sub> desaturation during apnea. Note that arterial O<sub>2</sub> desaturation is substantially right-shifted with increased . (B) Sensitivity of to changes in pre-apneic (). Note that reduced has a major impact on but little impact on ; the influence on is small in the normal range but becomes stronger at low . n = ‘normal’ 'values; S1, stage 1 slope; S2, stage 2 slope.</p

    Pulmonary gas exchange during apnea.

    No full text
    <p>(A) Rate of pulmonary O<sub>2</sub>/CO<sub>2</sub> exchange. and fall from resting levels during apnea. (B) Net alveolar-capillary gas uptake () and respiratory exchange ratio ()during apnea. (C) Changes in alveolar, arterial and mixed venous during apnea. Contrast the time-course in and as they fall/rise towards . (*) represents the fall in if was assumed equal to . S1 = stage 1; S2 = stage 2.</p

    Impact of R-L shunt (Fs) on .

    No full text
    <p>(A) Effect of three levels of Fs, (i) 0%, (ii) 15%, and (iii) 30%, on arterial () and mixed venous () O<sub>2</sub> during apnea. Note that resting R-L shunt fraction has a negligible impact on during apnea. (B) Sensitivity of to changes in Fs. n = ‘normal’ values; S1, stage 1 slope; S2, stage 2 slope.</p

    Conceptual framework depicting the temporal sequence of influence of the key cardiorespiratory factors on .

    No full text
    <p>Note the regions of influence of lung volume (), cardiac output () and blood volume (), each with respect to metabolic O<sub>2</sub> consumption (). Hemoglobin content (Hb) influences the latter phase of stage 1 as well as stage 2. The impact of reduced is limited to stage 1, and blood volume to stage 2. Reduced causes a leftward shift in the desaturation trajectory. Note that the point of inflection at the transition between stages reveals the resting .</p

    Model schematic representing O<sub>2</sub> uptake, transport and consumption.

    No full text
    <p>O<sub>2</sub> stores are represented by the alveolar, arterial, and venous compartments. Two dynamically-independent levels of O<sub>2</sub> uptake are denoted: pulmonary O<sub>2</sub> uptake () and metabolic consumption (). R-L shunt is also included. T<sub>a</sub> is the arterial transit time. Symbols are described in <a href="http://www.ploscompbiol.org/article/info:doi/10.1371/journal.pcbi.1000588#pcbi-1000588-t001" target="_blank">Table 1</a>.</p

    Impact of hemoglobin content (Hb) and O<sub>2</sub> affinity (P<sub>50</sub>) on .

    No full text
    <p>(A) Effect of three levels of Hb, (i) 12 g dl<sup>−1</sup>, (ii) 8 g dl<sup>−1</sup> and (iii) 4 g dl<sup>−1</sup>, on arterial () and mixed venous () O<sub>2</sub> desaturation during apnea. Note the fall in at the inflection point (shown by short black lines). Note also that the reduced Hb has little impact on desaturation above . (B) Sensitivity of to changes in Hb. (C) Effect of three levels of P<sub>50</sub>, (iv) 18 mmHg, (v) 24 mmHg, and (vi) 36 mmHg, on . (D) Sensitivity of to changes in P<sub>50</sub>. n = ‘normal’ values; S1, stage 1 slope; S2, stage 2 slope.</p

    The time course of during apnea.

    No full text
    <p>Panel (A) shows the increase in the slope of the oxy-hemoglobin dissocation curve at the level of alveolar (), and the fall in pulmonary oxygen uptake () that occurs during apnea. Panel (B) shows that changes in the product explain the time course of the instantaneous slope of arterial O<sub>2</sub> desaturation () during apnea. Note that the peak occurs when is substantially less than its resting value. Note also that the rate of fall of mixed-venous saturation () and become equal and constant after 20 s.</p
    corecore